SureTrader SureTrader
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

EPGL RSS Feed
Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, flaflyersfan, integral, Stock Barber, BADALI, baryoboy
Search This Board:
Last Post: 9/27/2016 12:04:35 PM - Followers: 472 - Board type: Free - Posts Today: 22
 

                         


About the Company:

EP Global Communications, Inc. is an Advanced Technology Research and Development company for both Medical Devices and Consumer Electronics Devices specializing in Microelectronic Mechanical Systems (MEMS). For more information about the company, please click on the banner above to be directed to the comapny website.

People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.


One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company has significant know-how and Intellectual Property in the arena of BioMEMS and has invented new device technologies which include, but are not limited to the following:
 
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
 
EPGL develops advanced technololgies and in negotiations currently to license them to medical device companies and consumer electronic companies.

Contract with CooperVision:
EPGL and CooperVision, Inc. (CooperVision) have signed an exclusive Development Agreement for Advanced Ophthalmic and Medical Technologies. CooperVision is a market leader in the manufacturing and marketing of contact lenses. The Cooper Companies recently completed the acquisition of Sauflon Pharmaceuticals Limited for approximately $1.2 Billion Dollars.

Material Disclosure to Shareholdrs EPGL MED JOINT PATENT VALIDATION
(Includes EPGL MED, COOPERVISION, David T.Markus, Aurthur Back, Luke A.Kilyk, Michael Hayes)

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=141220
 

Exclusive Development Agreement Signed with CooperVision, Inc., a Division of The Cooper Companies, Inc. (COO, NYSE)
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=125904



Contract with Intel:
On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an Initial Agreement. Additional Agreements are now pending. EPGL management believes that a relationship with Intel will be advantageous to shareholders as the two companies have synergistic goals in various fields. Details of further Agreements will be available upon mutual decision of the parties to disclose them publicly.

On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an initial Agreement. Additional Agreements are now pending.
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=127990
 


Contract with AT&T: 
A new Development Agreement has been executed between AT&T and EPGL on January 4, 2015. As a result of this agreeement Joint Intellectual Properties are now being developed certain data streaming projects in mind. EPGL continues to create new and innovative technologies with large companies
New** EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties (4/28/15)
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=136848

EPGL and AT&T Developing Joint Intellectual Properties Companies Sign Development Agreement Resulting in New Inventions in IoT Data Streaming Space
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=133983

EPGL and AT&T Sign Development Agreement
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=132040



About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so. As of Start of January 2015 Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares.  Reduction of A/S and O/S is currently ongoing and first evidence of EPGL reducing shares will be shown in upcoming Quartley Report  Q3, 2015
LINKS TO SHARE RETIREMENT
** Press Release **  - Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares Beginning January 2015

** OTC Disclosure ** - Supplemental Information- Retirement of Common Shares by Beneficial Shareholders Commences

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) Worlds Largest Accounting Firm
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restructure in 2012***
Total number of shareholders of record 700 approximate 

ISSUERS FACILITIES
The Company leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**




Additional Information :
Letter From PricewaterhouseCoopers (Ian Stokoe) Congratulating EPGL on First  Devlopment Agreement (CooperVision)

Follow EPGL on Twitter @epglMED  https://twitter.com/EPGLMed
Follow EPGL on the WEB at http://www.epglmed.com





 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EPGL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#108787  Sticky Note EPGL Wins Allowance on First Patent vikingzskillz 08/30/16 10:08:17 PM
#95482  Sticky Note Press releases or other company communication should not Brian !!Retired!! 01/12/16 12:14:18 PM
#109859   wow - I just noticed. Atlanta1 09/27/16 12:04:35 PM
#109858   "Hayes wants to shift into a higher gear, Stock Barber 09/27/16 12:01:14 PM
#109857   Apples and oranges... Stock Barber 09/27/16 11:57:52 AM
#109856   J&J's similar IP the(Thinned Flexible Circuit Board) # judypudy 09/27/16 11:53:43 AM
#109855   2 year time table and they are already Valiant 09/27/16 11:27:44 AM
#109854   Volume of shares traded Says it All. AJCash 09/27/16 11:06:26 AM
#109853   so how fast EPGL can produce working nowy257 09/27/16 10:58:38 AM
#109851   Because they can then they always have a Valiant 09/27/16 10:41:57 AM
#109849   Actually, quite the opposite! Shotime66 09/27/16 10:32:27 AM
#109848   If EPGL are in race with J&J and AJCash 09/27/16 10:07:44 AM
#109846   Loving the potential here! Gonna buy me epglholder 09/27/16 09:36:16 AM
#109845   "Many patents filed have potential to be used Stock Barber 09/27/16 09:26:37 AM
#109844   Nice post Gordon! It's why I found CancunCharlie 09/27/16 09:26:36 AM
#109843   Agree! Many patents filed have potential to be vikingzskillz 09/27/16 01:38:38 AM
#109842   Defined spaces patent is huge as well. Valiant 09/27/16 01:30:57 AM
#109841   Patent dealing with "Ciliary" if allowed will be vikingzskillz 09/27/16 01:29:33 AM
#109840   A lot of good stuff, most significant in vikingzskillz 09/27/16 01:24:50 AM
#109839   Did you get a chance to watch conference vikingzskillz 09/27/16 01:16:22 AM
#109838   Where's the list? Where's the list?? Where's the Doubledown22 09/27/16 01:03:58 AM
#109837   Nice post Gordon, EPGL truly the real deal! vikingzskillz 09/26/16 11:04:08 PM
#109836   I don't care as long it is Michael, vikingzskillz 09/26/16 10:44:33 PM
#109835   vikingzskillz, you do not think the author is flaflyersfan 09/26/16 10:41:03 PM
#109834   What if he does or not?? vikingzskillz 09/26/16 10:36:32 PM
#109833   vikingzskillz, does Brady write every tweet? EOM flaflyersfan 09/26/16 10:35:12 PM
#109832   Twitter permits only 140 characters in a tweet, vikingzskillz 09/26/16 10:22:30 PM
#109831   we have seen for a while that this Atlanta1 09/26/16 10:22:15 PM
#109830   So who was tweeting? Stock Barber 09/26/16 10:13:42 PM
#109829   vikingzskillz, who wrote these grammar-challenged tweets and who flaflyersfan 09/26/16 09:27:47 PM
#109828   Answer this question??? can anyone tell me Gordon111 09/26/16 09:19:47 PM
#109827   Yup. Looking good! Progress continues. H8ster 09/26/16 08:53:34 PM
#109824   It may pop but to get a huge baryoboy 09/26/16 07:20:00 PM
#109822   I'm not excited with the flat tire conference skorz 09/26/16 06:05:47 PM
#109820   It means $EPGL has MORE than the attention gr8f1 09/26/16 04:00:38 PM
#109819   On question number 2),I know the answer! Donguri 09/26/16 03:27:26 PM
#109818   OK, so the progress on the "2 year Stock Barber 09/26/16 03:03:16 PM
#109817   Can you post the exchange with coo as well Bibioo 09/26/16 02:49:32 PM
#109816   Here's an exchange that very well may have Atlanta1 09/26/16 02:42:55 PM
#109814   Thus JNJ & EPGL Atlanta1 09/26/16 02:33:42 PM
#109813   $EPGL already accomplished and built the MEMS that vikingzskillz 09/26/16 02:31:44 PM
#109812   $EPGL team does not build sophisticated MEMS at vikingzskillz 09/26/16 02:31:05 PM
#109811   I think those comments reflect a clear picture Atlanta1 09/26/16 01:54:53 PM
#109810   This is total B.S.Wait,Wait, Wait.That's all we ever stokjunky 09/26/16 01:52:35 PM
#109809   "They have multiple facilities they use." Stock Barber 09/26/16 01:48:35 PM
#109808   They need to stop having meeting just like Sone 09/26/16 01:39:54 PM
#109807   Very easily. Valiant 09/26/16 01:20:55 PM
#109806   He also noted they are much further Atlanta1 09/26/16 01:06:25 PM
#109805   That is not true. They have been Valiant 09/26/16 01:03:10 PM
#109804   Nope he said they were already in the Valiant 09/26/16 01:01:45 PM
#109803   They have multiple facilities they use. They Valiant 09/26/16 01:00:55 PM
#109802   If there was any R&D happening after the Stock Barber 09/26/16 12:53:07 PM
PostSubject